Medpace Holdings (MEDP) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY18 EPS Outlook Above Consensus

Go back to Medpace Holdings (MEDP) Tops Q4 EPS by 1c, Beats on Revenue; Offers FY18 EPS Outlook Above Consensus

Medpace (MEDP) PT Raised to $42 at Credit Suisse

February 27, 2018 8:15 AM EST

Credit Suisse raised its price target on Medpace (NASDAQ: MEDP) to $42.00 (from $41.00) while maintaining a Outperform rating.

... More